Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 6, 2014, Pages 512-516

  Alshareef, Rayan A ^a   Garg, Sunir J ^a   Hsu, Jason ^a   Vander, James ^a   Park, Carl ^a   Spirn, Marc J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERVENTION STUDY; MACULAR THICKNESS; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTCOME ASSESSMENT; RETINA MACULA EDEMA; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VERY ELDERLY; VISUAL ACUITY; COMPLICATION; DRUG EFFECTS; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; RECURRENT DISEASE; RETINAL VEIN OCCLUSION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RECURRENCE; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84903696227     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0072     Document Type: Article

References (24)

1. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch. Ophthalmol. 115:486-491, 1997.
2. Boyd, S.R., Zachary, I., Chakvarthy, U., et al. Correlation of increased vascular endothelial growth factor with neo-vascularization and permeability in ischemic central vein occlusion. Arch. Ophthalmol. 120:1644-1650, 2002.
3. Aiello, L.P., Avery, R.L., Arrigg, P.G., et al. Vascular en-dothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994.
4. Sears, J.E., and Hoppe, G. Triamcinolone acetonide destabilizes VEGF mRNA in Muller cells under continuous cobalt stimulation. Invest. Ophthalmol. Vis. Sci. 46:4336-4341, 2005.
5. Qian, J., Lu, Q., Tao, Y., and Jiang, Y.R. Vascular endo-thelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy. Retina. 31:161-168, 2011
6. American Society of Retina Specialists Annual Preferences and Trends Survey, 2010. www.asrs.org; access for members only.
7. Hsu, J., Kaiser, R.S., Sivalingam, A., Abraham, P., et al. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina. 27:1013-1019, 2007.
8. Brown, D.M., Campochiaro, P.A., Singh, R.P., et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 117:1124-1133, 2010.
9. Haller, J.A., Bandello, F., Belfort, R., Jr., et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 117:1134-1146, e1133, 2010.
10. Ramezani, A., Entezari, M., Moradian, S., et al. Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial. Graefes Arch. Clin. Exp. Oph-thalmol. 244:1601-1606, 2006.
11. Ip, M.S., Gottlieb, J.L., Kahana, A., et al. Intravitreal tri-amcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch. Ophthalmol. 122:1131-1136, 2004.
12. Ip, M.S., Scott, I.U., VanVeldhuisen, P.C., Oden, N.L., Blodi, B.A., Fisher, M., Singerman, L.J., Tolentino, M., Chan, C.K., and Gonzalez, V.H.Arandomized trial comparingthe efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch. Ophthalmol. 127:1101-1114, 2009. Erratum in: Arch. Ophthalmol. 127:1648, 2009.
13. Domalpally, A., Blodi, B.A., Scott, I.U., Ip, M.S., Oden, N.L., Lauer, A.K., and VanVeldhuisen, P.C. The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. Arch. Ophthalmol. 127:1461-1467, 2009.
14. Jonas, J.B., Libondi, T., Schlichtenbrede, F., and Schmid-bauer, M. Intravitreal triamcinolone after intravitreal bev-acizumab for retinal vein occlusions. Acta Ophthalmol. 88:e24-e25, 2010.
15. Rosenfeld, P.J., Fung, A.E., and Puliafito, C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg. Lasers Imaging. 36:336-339, 2005.
16. Iturralde, D., Spaide, R.F., Meyerle, C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 26:279-284, 2006.
17. Costa, R.A., Jorge, R., Calucci, D., et al. Intravitreal bev-acizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO Study. Retina. 27:141-149, 2007.
18. Beutel, J., Ziemssen, F., Luke, M., et al. Intravitreal bev-acizumab treatment of macular edema in central retinal vein occlusion: one-year results. Int. Ophthalmol. 30:15-22, 2010.
19. Schaal, S., Kaplan, H.J., and Tezel, T.H. Is there tachy-phylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology. 115:2199-2205, 2008.
20. Forooghian, F., Cukras, C., Meyerle, C.B., Chew, E.Y., and Wong, W.T. Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina. 29:723-731, 2009.
21. Fulya Ilhan, Ulku Celiker, Ahmet Godekmerdan, Emrah Kan, et al. The Antiphospholipid Antibody Syndrome Research in Patients with Retinal Venous Occlusion. Arch. Med. Res. 36:372-375, 2005.
22. Green, W.R., Chan, C.C., and Hutchins, G.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans. Am. Ophthalmol. Soc. 371-422, 1981.
23. Leopold, I.H. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears, M.L., Tarkkanen, A., eds. Surgical Pharmacology of the Eye. New York: Raven Press, 1985; p. 83-133.
24. Penfold, P.L., Wong, J.G., Gyory, J., and Billson, F.A. Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin. Experiment. Ophthalmol. 29:188-192, 2001.